ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "ANCA"

  • Abstract Number: 0418 • ACR Convergence 2021

    Longitudinal Patterns of Renal Function in ANCA-Associated Vasculitis

    Jennifer Hanberg1, Xiaoqing Fu1, Claire Cook2, John Stone3, Hyon K. Choi4 and Zachary Wallace5, 1Massachusetts General Hospital, Boston, MA, 2Division of Rheumatology, Allergy, and Immunology, Mass General Hospital, Boston, MA, 3Massachusetts General Hospital Rheumatology Unit, Harvard Medical School, Boston, MA, 4Massachusetts General Hospital, Lexington, MA, 5Massachusetts General Hospital, Newton, MA

    Background/Purpose: Renal involvement is common in ANCA-associated vasculitis (AAV). Prior analyses show that end stage renal disease (ESRD) in AAV may be multifactorial. Little is…
  • Abstract Number: 0281 • ACR Convergence 2020

    ANCA in SLE: Prevalence and Predictor Factors

    Reza Mirza1, Murray Urowitz2, Jiandong Su3 and Dafna Gladman4, 1University of Toronto, Toronto, ON, Canada, 2University Health Network, University of Toronto, Toronto, ON, Canada, 3University of Toronto Lupus Clinic, Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, University Health Network, Toronto, ON, Canada, 4Krembil Research Institute, Toronto Western Hospital, Toronto, ON, Canada

    Background/Purpose: SLE is a systemic autoimmune disease notable for the ability to affect nearly every tissue, and is associated with a breadth of auto-antibodies. Anti-neutrophilic…
  • Abstract Number: 1419 • ACR Convergence 2020

    Clinical Disease Might Be Divided into Two Phenotypes in ANCA Associated Vasculitis; Results of a Cluster Analysis

    Elif Ediboglu1, Onay Gercik2, Emre Bilgin3, Dilek Solmaz4, Irfan Ocal5, Arzu Saglam6, Zeki Soypacacı2, Haluk Cinaklı5, Sedat Kiraz3, Ömer Karadağ7 and Servet Akar2, 1Izmir Katip Celebi University, Izmir, Izmir, Turkey, 2Izmir Katip Celebi University, Izmir, Turkey, 3Hacettepe University, Ankara, Turkey, 4Izmir Katip Celebi University, Department of Internal Medicine, Division of Rheumatology, Izmir, TURKEY, Izmir, Turkey, 5Izmir Katip Celebi University, Izmir, 6Hacettepe University, Ankara, 7Hacettepe University, Faculty of Medicine, Department of Internal Medicine, Division of Rheumatology, Ankara,, Ankara, Turkey

    Background/Purpose: One of the controversial matters in ANCA associated vasculitis is the definition of disease based on clinical characteristics since there is a remarkable overlap…
  • Abstract Number: 1420 • ACR Convergence 2020

    Characterization of ANCA-Associated Vasculitis Among African American Patients

    Sehris Khawaja1, Saloni Godbole1, Maryann Kimoto2, Virginia Steen3 and Kaitlin Quinn4, 1Georgetown University, Washington, DC, 2UCLA, Los Angeles, CA, 3Division of Rheumatology, Department of Medicine, MedStar Georgetown University Hospital, Washington, DC, 4National Institutes of Health, Washington, DC

    Background/Purpose: ANCA-associated vasculitis (AAV) comprises a group of disorders characterized by inflammation of small and medium-sized arteries.  Prevalence and phenotype of these diseases appear to…
  • Abstract Number: 1421 • ACR Convergence 2020

    Clinical Features, Disease Activity and Prognosis of ANCA-Associated Vasculitis in US African Americans

    Luis Palomino1, Angelo Gaffo2, Sebastian Sattui3 and Dongmei Sun2, 1University of Alabama at Birmingham Hospital, Birmingham, AL 2University of Alabama at Birmingham, Birmingham, AL, 3Hospital for Special Surgery, New York, NY

    Background/Purpose: ANCA-associated vasculitis (AAV), including Granulomatosis with Polyangiitis (GPA), Eosinophilic Granulomatosis with Polyangiitis (EGPA) and Microscopic Polyangiitis (MPA), affect mostly Caucasians of European descent. Clinical…
  • Abstract Number: 1430 • ACR Convergence 2020

    The Role of Lung Biopsy in Pediatric ANCA-associated Vasculitis

    Edouard Sayad1, Tiphanie Vogel1, David Moreno McNeill1, Nahir Cortes-Santiago1, David Spielberg1, Kalyani Patel1 and Manuel Silva Carmona1, 1Baylor College of Medicine/Texas Children's Hospital, Houston, TX

    Background/Purpose: Anca-associated vasculitis (AAV) is characterized by vascular inflammation in multiple organs. The diagnosis can be made clinically using a number of different criteria. The…
  • Abstract Number: 1432 • ACR Convergence 2020

    Thyroid Disease in Patients with ANCA-Associated Vasculitis

    Tanaz Kermani1, David Cuthbertson2, Simon Carette3, Nader Khalidi4, Curry L. Koening5, Carol Langford6, Carol McAlear7, Paul Monach8, Larry Moreland9, Christian Pagnoux10, Philip Seo11, Ulrich Specks12, Antoine Sreih13, Kenneth Warrington12 and Peter Merkel13, 1University of California Los Angeles, West Hills, CA, 2University of South Florida, Tampa, 3Division of Rheumatology, Mount Sinai Hospital and University Health Network, University of Toronto, Toronto, ON, Canada, 4McMaster University, Hamilton, ON, Canada, 5University of Utah, Salt Lake City, 6Cleveland Clinic, Moreland Hills, OH, 7University of Pennsylvania, Philadelphia, 8Brigham and Women's, Boston, 9University of Pittsburgh, Denver, CO, 10Vasculitis Clinic, Canadian Network for Research on Vasculitides (CanVasc), Department of Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada, 11Johns Hopkins University, Baltimore, MD, 12Mayo Clinic, Rochester, MN, 13University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Prior studies have found increased prevalence of thyroid disease in patients with ANCA-associated vasculitis (AAV), especially positive myeloperoxidase (MPO)-ANCA, but a majority of the…
  • Abstract Number: 1433 • ACR Convergence 2020

    Thyroid Disease in ANCA-associated Vasculitis. a Population-based Study

    Anna Wilding1, Rona Smith2, David Jayne3, Mårten Segelmark4 and Aladdin Mohammad5, 1Lund University, Staffanstorp, Sweden, 2University of Cambridge, Cambridge, United Kingdom, 3Department of Medicine, Vasculitis and Lupus Research Group, University of Cambridge, Cambridge, UK, Cambridge, United Kingdom, 4Lund University, Lund, 5Lund University, Lund, Sweden. Department of Medicine, Vasculitis and Lupus Research Group, University of Cambridge, Cambridge, UK, Lund, Sweden

    Background/Purpose: A higher incidence of thyroid disease has been seen in patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). We aim to assess the incidence…
  • Abstract Number: 1435 • ACR Convergence 2020

    Prognostic Factors for Mononeuritis Multiplex Associated with ANCA-associated Vasculitis

    Yutaro Hayashi1, Satoshi Hama2, Keisuke Izumi2, Mari Ushikubo1, Misako Konishi3, Yutaka Okano4 and Hisaji Ohshima2, 1Tokyo medical center, Tokyo, Japan, 2Department of Connective Tissue Diseases, National Hospital Organization Tokyo Medical Center, tokyo, Japan, 3Tokyo medical center, toukyouto Meguroku, Japan, 4Department of Connective Tissue Diseases, National Hospital Organization Tokyo Medical Center, Kawasaki, Japan

    Background/Purpose: ANCA-associated vasculitis (AAV) sometimes presents mononeuritis multiplex which worsens the prognosis and activity of daily living in patients. This study aimed to determine theprognostic factorsand…
  • Abstract Number: 1439 • ACR Convergence 2020

    Proteinase 3-Reactive B Cell Pool Restructuring After Rituximab and Risk of Relapse in Severe PR3-ANCA-Associated Vasculitis

    Alvise Berti1, Sophie Hillion2, Marta Casal Moura1, Amber Hummel1, Eva Carmona1, Tobias Peikert1, Carol Langford3, Peter A. Merkel4, Paul Monach5, Philip Seo6, Robert Spiera7, Eugene St Clair8, Fernando C. Fervenza1, Kristina Harris9, John H. Stone10, Jacques-Olivier Pers11, Ulrich Specks1 and Divi Cornec12, 1Mayo Clinic, Rochester, MN, 2Brest University, Brest, Bretagne, France, 3Cleveland Clinic, Moreland Hills, OH, 4Division of Rheumatology University of Pennsylvania, Philadelphia, PA, 5Brigham and Women's, Boston, 6Johns Hopkins University, Baltimore, MD, 7Division of Rheumatology, Hospital for Special Surgery, New York, New York, USA, New York, NY, 8Duke University, Durham, NC, 9Immune Tolerance Network, Bethesda, MD, 10Massachusetts General Hospital Rheumatology Unit, Harvard Medical School, Boston, MA, 11University of Brest, Brest, France, 12Rheumatology Department, Brest University Hospital, Brest, France

    Background/Purpose: In ANCA-associated vasculitis (AAV) B cells play a central pathogenic role and are instrumental for the production of ANCA, which are thought to mediate…
  • Abstract Number: 1440 • ACR Convergence 2020

    The Myeloperoxidase (MPO) Anti-Neutrophilic Cytoplasmic Antibody (ANCA) Binding Epitope, MPO447-459 Induces CD4 T-cell Proliferation in Patients with MPO-ANCA-associated Vasculitis

    Matthew Terrill1, Hendrik Nel2, Yassmin Musthaffa3, Wong Richard4, Ross Francis5, David Johnson5, Greg Keir6, David Gillis7 and Ranjeny Thomas8, 1University of Queensland Diamantina Institute and Princess Alexandra Hospital, Rheumatology Department, Brisbane- Australia, Moffat beach, Queensland, Australia, 2University of Queensland Diamantina Institute, Brisbane, Queensland, Australia, 3University of Queensland Diamantina Institute, Brisbane, Australia, 4Immunology Department, Princess Alexandra Hospital, Brisbane- Australia, Brisbane, Australia, 5Renal Department, Princess Alexandra Hospital, Brisbane- Australia., Brisbane, Queensland, Australia, 6Respiratory Department, Princess Alexandra Hospital, Brisbane- Australia., Brisbane, Queensland, Australia, 7Immunopathology Department, Royal Women’s and Children’s Hospital, Brisbane- Australia., Brisbane, Queensland, Australia, 8University of Queensland Diamantina Institute and Rheumatology Department, Princess Alexandra Hospital, Brisbane – Australia., Brisbane, Australia

    Background/Purpose: In Myeloperoxidase (MPO) Anti Neutrophilic Cytoplasmic Antibody (ANCA)-Associated Vasculitis (MPO-AAV), murine and human studies suggest that the MPO435-465 region, which includes ANCA-binding MPO447-459, the…
  • Abstract Number: 2049 • ACR Convergence 2020

    Nasal Bacteria Associated with Disease Activity and ANCA Levels in Granulomatosis with Polyangiitis

    Rennie Rhee1, Jiarui Lu1, Kyle Bittinger2, Antoine Sreih1, Jung-Jin Lee3, Lisa Mattei3, Brendan Kelly4, Peter C. Grayson5, Hongzhe Lee4, Ronald Collman4 and Peter Merkel1, 1University of Pennsylvania, Philadelphia, PA, 2Children's Hospital of Philadelphia, Philadelphia, PA, 3Children's Hospital of Philadelphia, Philadelphia, 4University of Pennsylvania, Philadelphia, 5Systemic Autoimmunity Branch, National Institutes of Health, NIAMS, Bethesda, MD

    Background/Purpose: Nasal bacteria have been linked to disease activity in granulomatosis with polyangiitis (GPA) with most studies focused on Staphylococcus aureus. Our previous study identified…
  • Abstract Number: 068 • 2020 Pediatric Rheumatology Symposium

    Development of CARRA Consensus Treatment Plans for Severe ANCA-associated Vasculitis – Final CARRA-wide Consensus

    Linda Wagner-Weiner 1, Vidya Sivaraman 2, Karen James 3, Eric Yen 4, Kathleen O'Neil 5, Dana Gerstbacher 6, Ann Marie Szymanski7, Kimberly Morishita 8 and David Cabral 9 for the CARRA investigators, 1University of Chicago, Chicago, Illinois, 2Division of Rheumatology, Nationwide Children's Hospital, Bexley, 3University of Utah, 84113, Utah, 4UCLA, Los Angeles, California, 5University of Indiana School of Medicine, Indianapolis, Indiana, 6Stanford University School of Medicine, Palo Alto, California, 7Tampa, Florida, 8University of British Columbia - Vancouver, Vancouver, British Columbia, Canada, 9BC Children's Hospital and University of British Columbia, Vancouver, British Columbia, Canada

    Background/Purpose: Randomized trials for pediatric ANCA-associated vasculitis (ped-AAV) have not been feasible because of its rarity, therefore adult treatment strategies are usually adapted for children.…
  • Abstract Number: 102 • 2020 Pediatric Rheumatology Symposium

    Implications of Positive Tests for ANCA in a Pediatric Population

    Karen James1, Peter Merkel 2 and Aimee Hersh 3, 1University of Utah, 84113, Utah, 2University of Pennsylvania, Philadelphia, 3University of Utah Primary Children's Hospital, Salt Lake City

    Background/Purpose: Testing for ANCA, particularly performed by ELISA (anti-MPO/PR3) is highly sensitive and specific for ANCA-associated vasculitis (AAV). However ANCA testing may be used in…
  • Abstract Number: 871 • 2019 ACR/ARP Annual Meeting

    ANCA-Associated Vasculitis Management in the United States: Data from the RISE Registry

    Zachary Wallace1, Huifeng Yun 2, Jeffrey Curtis 2, Shuo Yang 2, Lang Chen 2, John Stone 3 and Hyon K. Choi 4, 1Massachusetts General Hospital, Boston, 2University of Alabama at Birmingham, Birmingham, AL, 3Massachusetts General Hospital Rheumatology Unit, Harvard Medical School, Boston, MA, 4Massachusetts General Hospital, Boston, MA

    Background/Purpose: The management of ANCA-associated vasculitis (AAV) evolved substantially in recent years because of evidence supporting the efficacy of various treatment regimens.  As such, treatment…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 20
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology